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Abstract
Endometriosis is a gynecological disease associated with inherited genetic traits. HOXA10 gene which 
is expressed in uterine plays an important role in the pathogenesis of endometriosis. The protein affects the 
development of pinopodes as a biomarker of endometrial receptivity in endometriosis.The aim of this study is 
to examine if there is a mutation or polymorphism within HOXA10 gene among patients with endometriosis. 
Thirty twopatients and 32 healthy women were recruited as subjects of this study. The exon 2 of HOXA10 
which covers most of coding region was amplifi ed using PCR. The presence of a mutation or polymorphism 
was detected by direct seguencing. The distribution of genotype and allele was analyzed using Chi square test 
with p<0.05 is considered as signifi cantly different. A novel heterozygous variant within exon 2 of HOXA10 
which substitute an adenine into thymine was detected at base position 55.  This missense alteration changed 
amino acid serine to cystein (Ser19Cys). Interestingly, this variant was detected  in 12 endometriosis cases (38%) 
but none in control. Patients carry HOXA10 Ser19Cys variant were associated with dismenorea and more 
frequent in stage I endometriosis. The role of this variant in the function of HOXA10 protein and frequency 
among Indonesians need to be clarifi ed. We found a novel heterozygous HOXA10 gene variant, Ser19Cys.The 
genotype frequency is 38% among endometriosis patients but none in control. This variant found in patient 
with dismenore and endometriosis stage 1.
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Introduction
Endometriosis is a gynecological disease 
marked by the presence of endometrial tissue 
proliferation outside the uterine cavity and 
is usually associated with menstrual pain 
and infértility. One important cause of 
endometriosis is retrograde menstruation 
that causes deposition of endometrial tissue 
in the peritoneal cavity. Endometriosis is a 
disease that gains a lot of attention but its 
exact ethiopathogenesis remains unknown. 
Infértility in endometriosis may occur at the 
time of pre implantation, implantation and 
post-implantation (Collette et al., 2006; Kim 
et al., 2007). Approximately 50% of women 
experiencing infértility were diagnosed as 
having endometriosis and when accompanied 
by pelvic pain or menstrual pain, the fi ndings 
of endometriosis reached 80% (Kao et al., 
2003). In 20 meta-analysis studies on the 
IVF-related outcomes from endometriosis 
patients concluded that either endometrial 
receptivity or the quality of oocytes or 
embryo infl uenced the declined pregnancy 
rates (Barnhart et al., 2002).
Endometrial eutopic of women with 
endometriosis is different from those without 
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endometriosis, in which the endometrium 
with endometriosis can express aromatase, 
the enzyme that catalyzes the production of 
estradiol. Increasing estradiol in endometrium 
can interfere with the implantation process 
in which blastocysts are anatomically 
and physiologically invading the uterine 
wall(Bulun et al., 2000; Huhtinen, 2010). 
The process of implantation requires the 
synchronized of conceptus development 
and endometrial receptivity, initiated by 
the process of apposition, adhesion and 
invasion followed by the transformation 
of endometrium into decidual until the 
formation of the placenta (Wu et al., 2005).
HOXA10 gene is thought to play roles in 
regulating gene expression, morphogenesis, 
and differentiation in endometrial cells. Its 
expression is regulated by estrogen and 
progesterone(Daftary et al., 2002). Progesterone 
and estrogen regulate expression of HOXA10 
in the endometrium, through the progesterone 
receptor (PR) and estrogen receptor (ER).
HOXA10 expression affects the development 
of pinopodes as a biomarker of endometrial 
receptivity (Murphy, 2000; Adam et al., 2002; 
Quinn et al., 2008). 
HOXA10 is required for the implantation 
process, directly acts to regulate cell adhesion 
molecules (CAM) such as ITGAVB3 (Taylor 
et al., 1999; Daftary et al., 2002). HOXA10 
expression in the endometrium has increased 
during ovulation (Bagot et al., 2000). The 
inhibition of HOXA10 expression would 
dramatically reduce the number of pinopodes 
(Lee and Mayo, 2004; Achache and Revel, 2006). 
A slight decrease of HOXA10 expression is seen 
in luminal area, glands, and endothelium, but is 
reduced signifi cantly in the area of  endometrial 
stromal endometriosis (Gui et al., 1999; Wu 
et al, 2005; Matsuzaki et al, 2009). HOXA10 
expression decreases in the endometrium’s 
endometriosis and followed by a defect in the 
expression of the target of HOXA10 gene such 
as EMX-2 and B3 integrin (Bagot et al., 2000; 
Daftary et al., 2002).
Both HOXA10 and ITGAVB3 appear in 
the window of implantation in the human 
endometrium, and the expression decrease 
in women with endometriosis and infértility 
(Lessey et al., 1994; Taylor et al., 1997; Achache 
and Revel 2006; Klemmt et al., 2006) as well as 
with the profi le (number and size) of pinopodes 
(Lee and Mayo, 2004; Achache and Revel, 
2006). However, several other researchers 
reported that there was norelationship 
between these conditions. It was found that 
involvement of multiple genes interacting 
in the pathogenesis ofendometriosis, so 
endometriosis is called the complex disease 
and the overall pathogenesis is unknown.
Whether proteomic changes of HOXA10 
and ITGAVB3 in the endometriosis are 
affected by genomic changes and whether 
the interaction of HOXA10 and ITGAVB3 
affects pinopodes or is an incidence that is 
unrelated need to be known as the basic of 
treatment of endometriosis. The aim of this 
study are to detect the presence of mutation 
or polymorphism in the HOXA10 gene and 
to compare its frequency in endometriosis 
patients with that in control at the time of 
the window of implantation. Thus, whether 
regulation of HOXA10 gene is caused by 
genetic defect which lead to low expression 
and promote the pathogenic process of 
endometriosis could be explained.
Materials and Methods
During the period of June 2010 to 
December 2011, 32 patients with endometriosis 
were enrolled in this study as case group. All 
data and blood from women who underwent 
laparoscopic and hysteroscopic surgery in 
Dr. Sarjito General Hospital and Islamic 
Hospital of Klaten were obtained. Thirty two 
healthy women underwent  minilaparotomic 
for tubectomi (MOW) surgery in Dr. Sarjito 
General Hospital were recruited as the control 
group. All patients had given their informed 
consent to participate and were willing to 
undergo surgery, blood sampling and data 
analysis. The protocol of this study has been 
approved by Ethical Research Committee of 
Medical and Health at Faculty of Medicine, 
Universitas Gadjah Mada, Yogyakarta.
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The data was collected in the same 
period between endometriosis patients with 
infértility and non-endometriosis and fértile 
patients. The control group was patients 
who underwent female sterilization. The 
data taken include dependent variables, 
independent variables and potential variables 
as confounding variables. The dependent 
variables were endometriosis and stage of 
endometriosis. 
Five mililiters of blood withdrawn 
from subjects was DNA extracted using 
standard method of phenol chloroform 
describe elsewhere. To detect the presence of 
polymorphism in the endometriosis among 
patients and controls, polymerase chain reaction 
(PCR) was used followed by direct sequencing. 
Primers flanking exon 2 of HOXA10 gene 
were design based on sequencing provided 
by Genatlas (http://genatlas.medecine.
univ-paris5.fr/) as follows : forward primer 
5’-ATG GGA GAA ACG GAG GCA ATT C-3’ 
and reverse primer 5’-AGT TCC TGG GCA 
GAG CCT GAA-3’. PCR was performed in a 
30 ul mixture reaction including 2ul ofDNA 
template,15 ul of PCR master mix (Promega®) 
containing Taq polymerase, dNTPs, MgCl2and 
PCR buffer, 1 ul of each primers and 11 ul 
distilled water.  PCR conditions consisted of 
initial denaturation at temperature of 95oC 
in 10 min, followed by 35 cycles consisting of 
denaturation of 95°C in 45 sec, annealing of 
590C in 45 sec, and extension at a temperature of 
720C in 45 sec, and ended with a fi nal extension 
at 72°C in 7 min. The total time required was 1 
h 56 min. Direct sequencing were performed 
using ABI Prism 310® (Applied Biosystem, 
Omaha) and the results were analyzed using 
software provided by the same company.
PCR products were visualized as a DNA band 
formed in the gelatin mold (2% agarose).
Result
The characteristic of subjects is shown 
in Table 1. 
The average of mean body mass index 
and endometriosis history in family were 
similar between the two groups, but average 
of age was higher in control group as women 
who want to undergo tubectomy usually 
have already many children. The frequency 
of dismenorea as a main symptom is higher 
in endometriosis group but parity is lower in 
infertile endometriosis group.
We identifi ed a heterozygous variant 
in the HOXA 10 gene at position 55 (A>T) 
leading to amino acid substitution from 
serine to cystein (Figure 1). This variant is 
novel because as our knowledge until the 
preparation of this manuscript, there was no 
previous report published in other journals 
and no data found both in Genebank and 
Genatlas on mutation and polymorphism 
database.
A genotype study of HOXA10 was 
carried out for all subjects. In this study it was 
discovered a variants in  exon 2 of HOXA10 
gene and after followed by sequencing the 
genes it found the base changes(A>T) in the 
position 55 bp in which the codon of AGT 
changed to TGT (Ser19Cys) or there was a 
change from amino acid of serine into systein 
in the position 19.
Analysis of Ser19Cys polymorphism 
HOXA10 with cinical characteristic in 
endometriosis groups showed that genetic 
variant were associated with dismenorea as 
a main  complain in endometriosis, and its 
frequency was higher in patient with stage 
I endometriosis.Of the 32 patients with 
endometriosis it was found 12 patients with 
Table 1. Basic Characteristics of patients with 
Endometriosis and Control
Variabel Endometriosis Control P
Age 33.31± 0.93 36 0.04
BMI 21.61± 0.29 22.49 ± 0.56 0.17
Parity 0.18 ± 0.09 2.75 ± 0.14 0.00
Dismenore
         + 24 (75.0%) 3 (9.4%) 0.001**
          - 8 (25.0%) 29 (90.6%)
Endo. Hystory
          + 8(25%) 3(9.38%) 0.1
          - 24(75%) 29(90.63%)
p ≤ 0.05 Sig. **; p < 0.1 Sig. *
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variant (38%) and it was not found in the 
controls. To clarify whether this variant is 
a mutation or polymorphism required in a 
study population and of protein study. It is 
also not clear whether this variant is specifi c 
to the population in Indonesia because there 
is no researcher reported it.
Discussion
Endometriosis is a disease that is often 
encountered and associated with genetic 
factors. One of expected genes playing a role in 
the pathogenesis of endometriosis is HOXA10 
gene. HOXA10 gene is an essential gene to 
identity the growth of reproductive  organsby 
regulating the proliferation of endometrial 
stromal cells and the morphogenesis of 
endometrial epithelial cell (Achache and 
Revel, 2006). HOXA10 gene also functions 
to maintain cell adhesion molecules like 
ITGAVB3. Disorders of the expression of 
HOXA10 cause disturbances on the process 
of epithelialization and decidualization by 
interfering with the expression of HOXA10 
gene target as ITGAVB3 and the expression 
of pinopodes. Disorders of the expression of 
pinopode cause disruptions in the process of 
apposition and disruption on the expression 
of ITGAVB3 that cause disruptions of the 
adhesion and invasion process. Disorders 
of HOXA10 expression can be caused by 
polymorphisms, mutations or methylation 
(Wu et al., 2005; Kim et al., 2007; Wu et al., 
2008).
Direct sequencing detected a variant in 
exon 2 of HOXA10 gene at position 55 which 
change adenine to thymine (A55T) leads to 
substitution of serine to cystein at amino acid 
position 19 (ser19cys). Of the 32 patients with 
endometriosis it was found 12 patients with 
change in nucleic acid (38%) and it was not 
found in the controls. It is not clear whether 
this variant is a mutation or polymorphism 
required in a study of protein. It is also not 
Table 2. Characteristic  of individuals with and without Ser19Cys polymorphism 
of HOXA10 gene among endometriosis’ patients
Variabel Polymorphism +        n  = 12
Polymorphism  –
       n = 20 P value
Mean Age 32 ± 1.24 34.05 ± 1.28 0.28
Mean BMI 21.53 ± 1.81 21.62 ± 1.65 0.84
Dismenore +/- 8/4 16/4 0.4
Mean Menars 15.08 ± 0.66 14.25 ± 1.61 0.10
Endo. Hystory (+/-) 3/9 5/15 1.00
Stage I 5 3 0.27
          II 3 10
          III 0 1
          IV 4 6
p ≤ 0.05 Sig. **; p < 0.1 Sig. *
 
 
SER/CYS
SER
A
T
Figure 1. Direct sequencing reveled a variant in exon 
2 of HOXA10 gene of a patient (top). It was found the 
adeninehas changed into thymineat position 55 (arrow) 
in which the codon of AGT changed to TGT (AGT → 
TGT) or changes in the amino acid Serine to Cystein 
(Ser19Cys). The bottom DNA sequence of a control 
shows no found the adeninechanged into thymine
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clear whether this variant is specifi c to the 
population in Indonesia that must still be 
proven because there is no researcher who 
has reported it.
HOXA10 mutations more frequently 
occurred in patients with endometriosis 
with less clinical symptoms. In the research 
reported by Wu et al. (2008), of 112 patients 
with endometriosis and 54 controls, 10.24% 
of patients were found several heterozygous 
mutations located in exon 1 and 2 with 
changes in the amino acid sequence. In 
another report, Wu et al. (2005) in a study on 
the promoter and intron 2 and 3 of HOXA10 
found the presence of methylation within 
the promoter and intron 1-2. Lalwani et al. 
(Lalwani et al., 2008) reported that 56 patients 
with non-endometriosis were not found 
mutations in HOXA10.
HOXA10 is needed to increase the 
endometrial responsiveness to progesterone 
during the implantation and the decidualization. 
Resistance to the progesterone explains the 
disruption of implantation and the failure 
in endometriosis treatment. The effect of 
Ser19Cys variant of HOXA10 gene remains 
to be clarifi ed. We speculate that this variant 
reduces the ability of protein to bind with gene 
undercontrolled by HOXA10 such as integrin 
and other genes encode adhesion molecules. 
This condition causes decrease in  the quality 
and quantity of pinopodes required for 
endometrial receptiveness leads to infertility. If 
it was the fact, as 38% of infertile endometriosis 
patients carry this variant, protein study is 
importent to clarify which gene is affected 
directly to this conditions. On the other hand, 
permanent hypermethylation of HOXA10 can 
cause endometriosis resistance to the treatment 
and the operative measures. An approach with 
a gene therapy by manipulating the expression 
of HOXA10 or with a therapy of demethylation 
agent improves methylation disruptions and is 
a potential treatment for endometriosis therapy 
in the future (Cakmak and Taylor, 2010).
In conclusion, we found a novel 
heterozygous variant, Ser19Cys, of HOXA10 
gene among patients with endometriosis 
in Indonesian population. The frequency 
genotype of this variant is 38% among 
endometriosis patients but none in control. 
This variant found in patient with dismenore 
and endometriosis stage 1.
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